This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Albemarle (ALB) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 5.21% and 1.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Huntsman (HUN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 7.95% and 3.38%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Stepan Co. (SCL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DuPont de Nemours (DD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 6.93% and 8.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
4 Stocks to Buy From the Prospering Diversified Chemical Industry
by Anindya Barman
An upswing in demand in major end markets from the pandemic-led downturn should enable the Zacks Chemicals Diversified industry to thrive. ALB, TROX, SCL and KRO are set to gain from the favorable industry fundamentals and strategic actions.
Stepan Co. (SCL) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 12.95% and 10.66%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Stepan Co. (SCL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Misses Q2 Earnings Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of -1.63% and 9.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Stepan Co. (SCL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Choose These 5 Low Leverage Stocks to Avoid Debt-Related Risk
by Aparajita Dutta
A risk-averse investor should buy stocks that bear low leverage since a debt-free corporation is rare to find. You may consider buying IMO, SCL, PIPR, DQ, and TRGP.
Stepan Company (SCL) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Stepan Company (SCL) has been struggling lately, but the selling pressure may be coming to an end soon
Dow Inc. (DOW) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Dow Inc. (DOW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Stepan Co. (SCL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Stepan Co. (SCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Huntsman (HUN) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Huntsman (HUN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Stepan Co. (SCL) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 27.27% and 5.84%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Stepan Company (SCL) Ahead of Earnings?
by Zacks Equity Research
Stepan Company (SCL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Stepan Co. (SCL) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 31.48% and 8.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Stepan Company (SCL) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Stepan Company (SCL) has been struggling lately, but the selling pressure may be coming to an end soon.
Stepan Co. (SCL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 11.43% and 1.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Stepan (SCL) This Earnings Season?
by Zacks Equity Research
Stepan (SCL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Stepan Co. (SCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Chemical Stocks to Snap Up on Global Manufacturing Revival
by Anindya Barman
With China seeing an economic rebound and manufacturing activities are improving around the world, things are looking up for the chemical industry.
Stepan Co. (SCL) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Stepan Co. (SCL) could produce exceptional returns because of its solid growth attributes.
Coronavirus Clouds Diversified Chemical Industry Outlook
by Anindya Barman
Diversified chemicals companies are buffeted by a downturn in demand across major markets and raw material cost pressure due to coronavirus.
Stepan Co. (SCL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Stepan Co. (SCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.